About the Project
The research study proposed here will leverage and enhance the DiPP facilities to enable the pharmaceutical industry to explore the benefits which IoT, simulation and other digitalisation technology can bring to their existing plants, by offering:
- Demonstration facilities to test and validate potential IoT applications in the real world.
- Cost-effective experimentation with production-class operational equipment, without the costly downtime and reduced output, if that were to be done on actual production machines.
- An opportunity to access and optimise low-level control systems in a pre-competitive environment.
For more information please contact Dr Peyman Moghadam ([Email Address Removed]), Dr Payam Soulatiantork ([Email Address Removed]) or Prof Mo Zandi ([Email Address Removed]).
If English is not your first language, then you must have International English Language Testing Service (IELTS) average of 6.5 or above with at least 6.0 in each component.
Based on your current searches we recommend the following search filters.
Based on your current search criteria we thought you might be interested in these.